Instil Bio Files 8-K for Disclosure and Exhibits
Ticker: TIL · Form: 8-K · Filed: May 22, 2025 · CIK: 1789769
| Field | Detail |
|---|---|
| Company | Instil Bio, INC. (TIL) |
| Form Type | 8-K |
| Filed Date | May 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, filing, sec
TL;DR
Instil Bio filed a routine 8-K, no major news.
AI Summary
Instil Bio, Inc. filed an 8-K on May 22, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial details or material events beyond the standard reporting requirements for this form.
Why It Matters
This 8-K filing indicates Instil Bio is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosure and exhibits, not indicating any new risks or material events.
Key Players & Entities
- Instil Bio, Inc. (company) — Registrant
- May 22, 2025 (date) — Date of Report
- 3963 Maple Avenue, Suite 350 Dallas, Texas 75219 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Instil Bio, Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to file Financial Statements and Exhibits.
On what date was this 8-K report filed?
The 8-K report was filed on May 22, 2025.
What is Instil Bio, Inc.'s principal executive office address?
Instil Bio, Inc.'s principal executive office is located at 3963 Maple Avenue, Suite 350, Dallas, Texas 75219.
What is Instil Bio, Inc.'s telephone number?
Instil Bio, Inc.'s telephone number is (972) 499-3350.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding Instil Bio, Inc. (TIL).